The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Isfahan University of Medical Sciences

Status and phase: Completed; Phase 4

Conditions: Type 2 Diabetic Patients

Treatments: Dietary Supplement: DASH diet; Dietary Supplement: a usual diabetic diet

Study type: Interventional

Funder types: Other

Identifiers

NCT01049321

DASH and cardiovascular risks

Details and patient eligibility

About

The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.

Enrollment: 36 patients

Sex: All

Ages: 44 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Having type 2 diabetes

Exclusion criteria

• Having other chronic disease, hepatic or kidney disorders, cancer, hormone therapy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

36 participants in 2 patient groups, including a placebo group

DASH diet

Experimental group

Description:

DASH: Dietary approaches to stop hypertension eating plan

Treatment:

Dietary Supplement: DASH diet

Diabetic diet

Placebo Comparator group

Description:

Diabetic diet: a usual diabetic diet

Treatment:

Dietary Supplement: a usual diabetic diet